Literature DB >> 16341997

Pediatric stroke: what do we know and what do we need to know?

John K Lynch1, Christina J Han.   

Abstract

Stroke is a heterogeneous disorder and an important cause of mortality and chronic morbidity in children. Estimates of international incidence rates for childhood stroke have varied widely. Arterial ischemic stroke is reported to be more common than hemorrhagic stroke in children. The clinical presentation of stroke in children differs according to the child's age and stroke type and location. Several risk factors for ischemic and hemorrhagic stroke in children have been reported and include cardiac disorders, blood disorders, vasculopathies, viral infections, and arteriovenous malformations. Current treatment recommendations for stroke in children are based on small nonrandomized trials, adult stroke studies, case series, or consensus or individual expert opinion. Over half of children with stroke will develop lifelong cognitive or motor disability, and up to a third will have a recurrent stroke. International studies have provided important information on stroke in children, but major gaps in our knowledge of the disorder still exist. Currently, there is a need for prospective cohort studies in diverse populations, which utilize a consensus pediatric stroke classification system and a standard evaluation of risk factors and outcome, so that treatment and prevention strategies can be developed.

Entities:  

Mesh:

Year:  2005        PMID: 16341997     DOI: 10.1055/s-2005-923535

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  16 in total

1.  Pediatric stroke: clinical characteristics, acute care utilization patterns, and mortality.

Authors:  Kimberly D Statler; Li Dong; Denise M Nielsen; Susan L Bratton
Journal:  Childs Nerv Syst       Date:  2010-10-05       Impact factor: 1.475

2.  Extensive and largely reversible ischemic cerebral infarctions in a prepubertal child with hypertension and Cushing disease.

Authors:  Jil Huong Nguyen; Maya B Lodish; Nicholas J Patronas; Figen Ugrasbul; Margaret F Keil; Mary D Roberts; Jadranka Popovic; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-01       Impact factor: 5.958

Review 3.  Hemorrhagic stroke in children.

Authors:  Lori C Jordan; Argye E Hillis
Journal:  Pediatr Neurol       Date:  2007-02       Impact factor: 3.372

4.  Hypoxia recruits intrapulmonary arteriovenous pathways in intact rats but not isolated rat lungs.

Authors:  Melissa L Bates; Brendan R Fulmer; Emily T Farrell; Alyssa Drezdon; David F Pegelow; Robert L Conhaim; Marlowe W Eldridge
Journal:  J Appl Physiol (1985)       Date:  2012-03-15

Review 5.  Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations.

Authors:  Lauren A Beslow; Lori C Jordan
Journal:  Childs Nerv Syst       Date:  2010-07-13       Impact factor: 1.475

Review 6.  Crossing the blood-brain barrier: clinical interactions between neurologists and hematologists in pediatrics - advances in childhood arterial ischemic stroke and cerebral venous thrombosis.

Authors:  Char Witmer; Rebecca Ichord
Journal:  Curr Opin Pediatr       Date:  2010-02       Impact factor: 2.856

7.  West Virginia University pediatric stroke registry: clinical description and risk factors identification in patients from a rural area.

Authors:  Paola Pergami; Sathees Waran Thayapararajah; Nirupama Seemaladinne
Journal:  Clin Pediatr (Phila)       Date:  2014-07-20       Impact factor: 1.168

8.  Pediatric and newborn stroke.

Authors:  Sharon Goodman; Steven Pavlakis
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

9.  Assessment and treatment of stroke in children.

Authors:  Lori C Jordan
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

10.  TrkB receptor agonist 7, 8 dihydroxyflavone triggers profound gender- dependent neuroprotection in mice after perinatal hypoxia and ischemia.

Authors:  Kutluay Uluc; Pınar Kendigelen; Emin Fidan; Louise Zhang; Vishal Chanana; Douglas Kintner; Erinc Akture; Chihwa Song; Keqiang Ye; Dandan Sun; Peter Ferrazzano; Pelin Cengiz
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.